Tina Nova

Tina Nova

Presidente presso EXAGEN INC.

Patrimonio netto: 360 863 $ in data 31/05/2026

72 anni
Health Technology
Commercial Services
Health Services

Profilo

Tina Susan Nova founded Ngen, Inc. in 1994, where she worked as President & Chief Operating Officer from 1994 to 2000, Genoptix, Inc. in 1999, where she worked as President, Chief Executive Officer & Director from 2000 to 2014, and Nanogen in 1994, where she worked as President & Chief Operating Officer from 1994 to 2000.
Dr. Nova also currently works at GenomeDx, Inc. (California), as Chief Executive Officer & Director from 2018, Exagen, Inc., as Executive Chairman from 2023, Rady Pediatric Genomics & Systems Medicine Institute, as Vice Chairman, and various other companies.
Dr. Nova also formerly worked at Veracyte SD, Inc., as President, Chief Executive Officer & Director from 2018 to 2021, Molecular Stethoscope, Inc., as President & Chief Executive Officer from 2015 to 2019, Biocom, Inc., as Chairman from 2001 to 2002, and various other companies.
Dr. Nova received her undergraduate degree from the University of California, Irvine and doctorate degree from the University of California, Riverside.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
06/02/2026 15.772 ( 0,03% ) 360 863 $ 31/05/2026
04/06/2026 0 ( -.--% ) - $ 31/05/2026
15/04/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Tina Nova

SocietàPosizioneInizio
EXAGEN INC. Presidente 19/01/2023
AZENTA, INC. Direttore/Membro del Consiglio 31/01/2023
AURINIA PHARMACEUTICALS INC. Direttore/Membro del Consiglio 15/05/2025
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Investitore di Private Equity -
Amministratore Delegato 01/08/2018
Direttore/Membro del Consiglio 09/11/2016
Rady Pediatric Genomics & Systems Medicine Institute
Direttore/Membro del Consiglio -
░░░░░░░░░░ ░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Tina Nova

SocietàPosizioneFine
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Tina Nova

Formazione di Tina Nova

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

62

Relazioni di 1° grado

30

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private30

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Services

Rady Pediatric Genomics & Systems Medicine Institute

Commercial Services

Miscellaneous

Health Technology

Health Technology

- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA